Literature DB >> 11591205

The pathogenicity of Clostridium difficile.

I R Poxton1, J McCoubrey, G Blair.   

Abstract

It is now well established that the major virulence factors of C. difficile are the two toxins A and B. However, the organism possesses an array of other putative virulence factors that may be important for localisation within the colon, and in evasion of the immune system. It has been observed that certain types of C. difficile are more commonly found causing disease than others, and this seems to be independent of toxin production. Is this simply a reflection of their abundance in the hospital environment, or is it due to their virulence determinants? This review covers our current knowledge of the modes of action of toxins A and B at the cellular and molecular level. Many unanswered questions are posed that require answers before we can fully understand the pathogenic mechanisms of the organism and be in a position to manage better the spectrum of diseases it causes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591205     DOI: 10.1046/j.1198-743x.2001.00287.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  43 in total

Review 1.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 2.  Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

3.  Mapping interactions between germinants and Clostridium difficile spores.

Authors:  Amber Howerton; Norma Ramirez; Ernesto Abel-Santos
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

4.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

5.  The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.

Authors:  Louis Lteif
Journal:  Hawaii J Med Public Health       Date:  2017-02

Review 6.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

7.  SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate.

Authors:  David A Burns; John T Heap; Nigel P Minton
Journal:  J Bacteriol       Date:  2009-11-20       Impact factor: 3.490

8.  Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors.

Authors:  Reeja Maria Cherian; Chunsheng Jin; Jining Liu; Niclas G Karlsson; Jan Holgersson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

9.  A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein.

Authors:  Jenny E Emerson; Catherine B Reynolds; Robert P Fagan; Helen A Shaw; David Goulding; Neil F Fairweather
Journal:  Mol Microbiol       Date:  2009-07-28       Impact factor: 3.501

10.  Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria.

Authors:  Shomik Sibartie; Ann M O'Hara; Jude Ryan; Aine Fanning; Jim O'Mahony; Shaun O'Neill; Barbara Sheil; Liam O'Mahony; Fergus Shanahan
Journal:  BMC Immunol       Date:  2009-10-08       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.